Glaucoma study finds brain fights to preserve vision

February 23, 2018 by Jessica Pasley, Vanderbilt University
Acute angle closure glaucoma of the right eye (intraocular pressure was 42 in the right eye). Credit: James Heilman, MD/Wikipedia

A team of researchers, led by David Calkins, Ph.D., vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve vision.

In addition, Calkins is encouraged that the findings released in the Proceedings of the National Academy of Sciences (PNAS) will have treatment ramifications to combat age-related neurodegenerative disorders like Alzheimer's and Parkinson's diseases.

The paper, "Axogenic Mechanism Enhances Retinal Ganglion Cell Excitability During Early Progression in Glaucoma," unmasked a revolutionary conclusion—in the past it was believed that as retinal activity is lost, the connection between the retina and the brain should be gone, but the opposite is true.

Calkins deemed the information one of the most significant discoveries since his team showed in 2010 that the first sign of injury in glaucoma occurs in the brain, and was similar to other age-related, central nervous system diseases.

"What we have demonstrated in our most recent study is that the brain fights back," said Calkins, Denis O'Day Professor of Ophthalmology and Visual Sciences and director of the Vanderbilt Vision Research Center. "And we identified the for what causes this compensatory response. We found that for a brief period of time this particular mechanism actually preserves , despite the onslaught of stress in glaucoma.

"This is a real paradigm shift," Calkins said. "The dogma has been that once started, neurodegenerative is a one-way path. But we found that individual fight back to maintain signaling between , thereby slowing progression. It's a balance between disease and adaptation.

"We think we can develop new therapies based on this mechanism to keep the optic nerve signaling, which will maintain vision even as a disease progresses."

Diseases of the central nervous system involve early degradation of axon function that often precede degeneration—basically as the disease progresses, the retina stops talking to the brain, and soon afterward the axons begin to degenerate, then the retina and finally the brain, explained Calkins.

The team used a model of glaucoma, the leading cause of irreversible blindness in the world, to record and compare how the loss of synapses relates to the diminishment of signals to the axon.

Neurons have specialized projections called dendrites and axons. Dendrites bring information to the cell body and axons take information away from the cell body.

Information from one neuron flows to another neuron across a synapse.

In neurodegenerative disorders of the brain, those synapses are lost as the neuron dies.

Calkins' team found that the axon signals did not diminish, rather the signaling to the brain increased, meaning that neurons were fighting back against the loss of excitatory activity.

"We discovered a sodium channel that usually sits far away from the cell body of the neuron," Calkins said. "As the dendrites are lost, the sodium channel moves closer to the cell body and whatever residual activity remains, the channel boosts and amplifies the axon signal to the brain and for a brief period of time this mechanism actually preserves vision."

"With this information, we hope to bootstrap this natural adaptive mechanism and prolong signaling between regions and prevent subsequent degeneration. As long as signaling is maintained, progression slows and vision is maintained.

"Now that we have identified the mechanism that causes adaptation, we can exploit it through new drugs or even gene therapy."

Explore further: Scientists discover potential treatment to stop glaucoma in its tracks

More information: Michael L. Risner et al. Axogenic mechanism enhances retinal ganglion cell excitability during early progression in glaucoma, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1714888115

Related Stories

Scientists discover potential treatment to stop glaucoma in its tracks

November 6, 2017
Vision scientists at the University of California, Berkeley, and the University of Toronto have discovered that naturally occurring molecules known as lipid mediators have the potential to halt the progression of glaucoma, ...

Is glaucoma a brain disease? Scientists find that jigsaw effect in glaucoma patients proves it is

June 6, 2014
Findings from a new study published in Translational Vision Science & Technology (TVST) show the brain, not the eye, controls the cellular process that leads to glaucoma. The results may help develop treatments for one of ...

Study identifies new target to preserve nerve function

July 14, 2017
Scientists in the Vollum Institute at OHSU have identified an enzyme that plays a crucial role in the degeneration of axons, the threadlike portions of a nerve cell that transmit signals within the nervous system. Axon loss ...

Stress pathway identified as potential therapeutic target to prevent vision loss

February 8, 2012
A new study identifies specific cell-stress signaling pathways that link injury of the optic nerve with irreversible vision loss. The research, published by Cell Press in the February 9 issue of the journal Neuron, may lead ...

Pain reliever may help relieve the vision damage of glaucoma

May 1, 2017
The tip of our optic nerve is typically the first place injured by glaucoma.

Recommended for you

Older adults with small social networks less likely to get cataract surgery

March 9, 2018
Close family relationships and a strong social network may help older adults see the world better—literally.

A retinal implant that is more effective against blindness

March 9, 2018
EPFL researchers have developed a new type of retinal implant for people who have become blind due to the loss of photoreceptor cells in their retinas. The implant partially restores their visual field and can significantly ...

New imaging technique could improve the diagnosis, treatment of glaucoma

March 7, 2018
The National Eye Institute, part of the National Institutes of Health, projects the number of Americans affected by glaucoma will more than double between 2010 and 2050, from 2.7 million to 6.3 million.

New gene therapy corrects a form of inherited macular degeneration in canine model

March 5, 2018
Researchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degeneration in a canine model. The work sets the stage for translating the findings into a human therapy ...

New insights into how the retina processes orientation

February 26, 2018
In a study published in Nature Communications, Northwestern Medicine scientists detail the discovery of two types of cells in the retina that determine horizontal or vertical orientation, and demonstrated for the first time ...

Glaucoma study finds brain fights to preserve vision

February 23, 2018
A team of researchers, led by David Calkins, Ph.D., vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.